FDA bans imports from Canadian drugmaker Apotex's India plant

The U.S. Food and Drug Administration banned imports from Canadian drugmaker Apotex Inc's manufacturing plant in India for not complying with quality standards, the latest in a series of sanctions against medicines produced in India. Drugs made at the plant, based in the southern Indian city of Bangalore, will be detained without physical examination because the factory did not meet the FDA's good manufacturing practices, the agency said on its website on Wednesday.



via Health News Headlines - Yahoo News http://ift.tt/1h6efhA